Abstract
In recent years there has been a significant growth in the development of technological innovations based on population genomic data, especially in the area of pharma/biotech industries. However, about 80% of the knowledge generated is based only on the genetic diversity of European populations. This lack of diversity in genomic databases leads to the loss of opportunities to make unprece…